ETH Zurich researchers have developed a new method of magnetic resonance imaging (MRI) for the early detection and better monitoring of multiple sclerosis (MS). The method maps the myelin sheaths in ...
How can imaging biomarkers enhance our understanding of MS? Dr Anne Cross and Dr Matthew Brier examine MRI advancements that ...
DelveInsight's Chronic Progressive Multiple Sclerosis Market Insights report includes a comprehensive understanding of current treatment practices, chronic progressive multiple sclerosis emerging ...
A study using wearable scanning technology has revealed how brain function differs in people with multiple sclerosis (MS). It ...
Researchers at University College London have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis ...
What should healthcare providers consider when advising patients at risk of or diagnosed with MS regarding the use of exogenous hormones, such as oral contraceptives, and their potential impact on ...
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a study titled A Randomized ...
One of the most advanced magnetic resonance imaging (MRI) scanners in the world for research was delivered to UB on Saturday. The scanner will enable Western New York researchers to make ...
Improved MRI scans of the myelin sheaths in the brain should allow multiple sclerosis to be detected at an early stage. Multiple sclerosis (MS) is a neurological disease that usually leads to ...
The chronic progressive multiple sclerosis market size is anticipated to grow during the forecast period (2025-2034). According to DelveInsight's analysis, this growth is expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback